Skip to content

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01893619
Acronym
immunoprop
Enrollment
100
Registered
2013-07-09
Start date
2013-06-30
Completion date
2013-12-31
Last updated
2013-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Keywords

Chronic fatigue syndrome, Karnofsky score, supplements

Brief summary

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Detailed description

Detailed questionnaire regarding the diagnosis of an onset of chronic fatigue syndrome and 100 patients. using Karnofsky scale before and after use of supplements patient scores are compared in a double blind trial.

Interventions

None listed

Sponsors

New York CFS Association
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection

Exclusion criteria

* non inclusion in the above criteria

Design outcomes

Primary

MeasureTime frameDescription
Karnovsky score comparisonSix monthsReview of Karnofsky score over prior to diagnosis and subsequent to patients having taken supplements

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026